WOMEN in Europe who happen to be of Ashkenazi Jewish descent may want to keep that fact from their doctor when being tested for breast cancer genes.
Myriad Genetics of Salt Lake City won a European patent on 1 July covering a specific mutation in the BRCA2 gene, which increases the risk of breast cancer. The mutation is found in 1 in 100 women of Ashkenazi Jewish descent. The ruling means that doctors offering tests for BRCA2 mutations are now legally obliged to ask women if they are Ashkenazi Jews. If they say they are, doctors must pay a…
